Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897621852> ?p ?o ?g. }
- W2897621852 abstract "Targeting the Immune Checkpoint molecules (ICs; CTLA-4, PD-1, PD-L1/2 and others) which provide inhibitory signals to T cells, dramatically improves survival in hard-to-treat tumors. The establishment of an immunosuppressive environment prevents endogenous immune response in glioblastoma; therefore, manipulating the host immune system seems a reasonable strategy also for this tumor. In glioma patients the accumulation of CD4+/CD8+ T cells and Treg expressing high levels of CTLA-4 and PD-1, or the high expression of PD-L1 in glioma cells correlates with WHO high grade and short survival. Few clinical studies with ICis were completed so far. Notably, the first large-scale randomized trial (NCT 02017717) that compared PD-1 blockade and anti-VEGF, did not show an OS increase in the patients treated with anti-PD-1. Several factors could have contributed to the failure of this trial and must be considered to design further clinical studies. In particular the possibility of targeting at the same time different ICs was preclinically tested in an animal model were inhibitors against IDO, CTLA-4 and PD-L1 were combined and showed persistent and significant antitumor effects in glioma-bearing mice. It is reasonable to hypothesize that the immunological characterization of the tumor in terms of type and level of expressed IC molecules on the tumor and TIL may be useful to design the optimal ICi combination for a given subset of tumor to overcome the immunosuppressive milieu of glioblastoma and to efficiently target a tumor with such high cellular complexity." @default.
- W2897621852 created "2018-10-26" @default.
- W2897621852 creator A5027281364 @default.
- W2897621852 creator A5046614274 @default.
- W2897621852 creator A5054714379 @default.
- W2897621852 creator A5062039245 @default.
- W2897621852 creator A5089984303 @default.
- W2897621852 date "2018-10-23" @default.
- W2897621852 modified "2023-10-18" @default.
- W2897621852 title "Immune Checkpoints and Innovative Therapies in Glioblastoma" @default.
- W2897621852 cites W1519521580 @default.
- W2897621852 cites W1787923008 @default.
- W2897621852 cites W1815157104 @default.
- W2897621852 cites W1967908989 @default.
- W2897621852 cites W1983973479 @default.
- W2897621852 cites W2012972418 @default.
- W2897621852 cites W2015387729 @default.
- W2897621852 cites W2015474424 @default.
- W2897621852 cites W2036742353 @default.
- W2897621852 cites W2053393698 @default.
- W2897621852 cites W2054695890 @default.
- W2897621852 cites W2057312839 @default.
- W2897621852 cites W2057658429 @default.
- W2897621852 cites W2065899910 @default.
- W2897621852 cites W2074792897 @default.
- W2897621852 cites W2075094265 @default.
- W2897621852 cites W2090031443 @default.
- W2897621852 cites W2096287682 @default.
- W2897621852 cites W2097049582 @default.
- W2897621852 cites W2097995306 @default.
- W2897621852 cites W2099418348 @default.
- W2897621852 cites W2101134045 @default.
- W2897621852 cites W2108933323 @default.
- W2897621852 cites W2114701172 @default.
- W2897621852 cites W2124199305 @default.
- W2897621852 cites W2124644546 @default.
- W2897621852 cites W2133499518 @default.
- W2897621852 cites W2148255040 @default.
- W2897621852 cites W2156389657 @default.
- W2897621852 cites W2184759047 @default.
- W2897621852 cites W2188381790 @default.
- W2897621852 cites W2190672185 @default.
- W2897621852 cites W2304485006 @default.
- W2897621852 cites W2330297703 @default.
- W2897621852 cites W2336076245 @default.
- W2897621852 cites W2351394388 @default.
- W2897621852 cites W2428936938 @default.
- W2897621852 cites W2463107800 @default.
- W2897621852 cites W2463645998 @default.
- W2897621852 cites W2550560229 @default.
- W2897621852 cites W2553733474 @default.
- W2897621852 cites W2557786287 @default.
- W2897621852 cites W2562815599 @default.
- W2897621852 cites W2583186038 @default.
- W2897621852 cites W2583978691 @default.
- W2897621852 cites W2586151920 @default.
- W2897621852 cites W2587536205 @default.
- W2897621852 cites W2587557951 @default.
- W2897621852 cites W2593059553 @default.
- W2897621852 cites W2603352326 @default.
- W2897621852 cites W2606528726 @default.
- W2897621852 cites W2612034094 @default.
- W2897621852 cites W2618481330 @default.
- W2897621852 cites W2620355301 @default.
- W2897621852 cites W2626614537 @default.
- W2897621852 cites W2643663241 @default.
- W2897621852 cites W2739763813 @default.
- W2897621852 cites W2764040657 @default.
- W2897621852 cites W2767426525 @default.
- W2897621852 cites W2793687808 @default.
- W2897621852 cites W2794763378 @default.
- W2897621852 cites W2803022581 @default.
- W2897621852 cites W3101467937 @default.
- W2897621852 cites W4248130349 @default.
- W2897621852 cites W4251944654 @default.
- W2897621852 doi "https://doi.org/10.3389/fonc.2018.00464" @default.
- W2897621852 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6206227" @default.
- W2897621852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30406030" @default.
- W2897621852 hasPublicationYear "2018" @default.
- W2897621852 type Work @default.
- W2897621852 sameAs 2897621852 @default.
- W2897621852 citedByCount "65" @default.
- W2897621852 countsByYear W28976218522019 @default.
- W2897621852 countsByYear W28976218522020 @default.
- W2897621852 countsByYear W28976218522021 @default.
- W2897621852 countsByYear W28976218522022 @default.
- W2897621852 countsByYear W28976218522023 @default.
- W2897621852 crossrefType "journal-article" @default.
- W2897621852 hasAuthorship W2897621852A5027281364 @default.
- W2897621852 hasAuthorship W2897621852A5046614274 @default.
- W2897621852 hasAuthorship W2897621852A5054714379 @default.
- W2897621852 hasAuthorship W2897621852A5062039245 @default.
- W2897621852 hasAuthorship W2897621852A5089984303 @default.
- W2897621852 hasBestOaLocation W28976218521 @default.
- W2897621852 hasConcept C126322002 @default.
- W2897621852 hasConcept C154317977 @default.
- W2897621852 hasConcept C167672396 @default.
- W2897621852 hasConcept C170493617 @default.
- W2897621852 hasConcept C202751555 @default.
- W2897621852 hasConcept C203014093 @default.